BioCatalyst

VRDN — Viridian Therapeutics, Inc.DE catalysts

1 verified catalyst event(s) for Viridian Therapeutics, Inc.DE (ticker VRDN). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-07-01 — A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07 (month)
in 9d
ESTIMATED
 READOUT
A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants Wi
Phase 3 · Thyroid Eye Disease
 VRDN Viridian Therapeutics, Inc.D VRDN-003, Autoinjector ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.